FDA Drug Application (020236) for SEREVENT by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number020236
Product Number001
FormAEROSOL, METERED;INHALATION
DosageEQ 0.021MG BASE/INH
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSEREVENT
Active IngredientSALMETEROL XINAFOATE

Active IngredientCount
List of drugs with Active Ingredient SALMETEROL XINAFOATE5


Back to FDA Applications sponsored by GLAXOSMITHKLINE